MimiClon<sup>®</sup>, Inc. Receives FDA Clearance for Concurrent Use of its Wound Management Devices
Columbia, MD – (March 23, 2016) – MimiClon, Inc. today announced that it has received additional FDA clearance for its Mimic Powder ® device, which describes the concurrent use of Mimic Powder ® in conjunction with MimiClon membrane® Wound Matrix or MimiClon membrane Burn Matrix devices. Mimic Powder —the micronized particulate form of MimiClon’s patented […]
